VivoSim Labs, Inc. (VIVS): Depreciation & Amortization
$215.0K
Year ended 2026-03-31
$194.0K
Trailing 12 months to 2026-06-30
-9.8%
3-year compound annual growth
+39.3%
5-year compound annual growth
-12.5%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $215.0K | -19.2% | 2026-07-14, From 2025-04-01 |
| 2025-03-31 | $266.0K | -5.0% | 2026-07-14, From 2024-04-01 |
| 2024-03-31 | $280.0K | -4.4% | 2025-06-05, From 2023-04-01 |
| 2023-03-31 | $293.0K | +106.3% | 2024-05-31, From 2022-04-01 |
| 2022-03-31 | $142.0K | +246.3% | 2023-07-14, From 2021-04-01 |
| 2021-03-31 | $41.0K | -96.4% | 2022-06-10, From 2020-04-01 |
| 2020-03-31 | $1.14M | +16.5% | 2021-06-15, From 2019-04-01 |
| 2019-03-31 | $980.0K | -22.7% | 2020-05-28, From 2018-04-01 |
| 2018-03-31 | $1.27M | +10.3% | 2019-06-03, From 2017-04-01 |
| 2017-03-31 | $1.15M | +41.0% | 2018-05-31, From 2016-04-01 |
| 2016-03-31 | $815.0K | +72.7% | 2018-05-31, From 2015-04-01 |
| 2015-03-31 | $472.0K | +22.0% | 2017-06-07, From 2014-04-01 |
| 2014-03-31 | $387.0K | n/a | 2016-06-09, From 2013-04-01 |
| No annual figure between 2012-12-31 and 2014-03-31. | |||
| 2012-12-31 | $195.0K | +186.8% | 2015-06-09, From 2012-01-01 |
| 2011-12-31 | $68.0K | n/a | 2014-06-10, From 2011-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $215.0K | -19.2% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $664.0K | -6.2% |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $364.0K | -9.9% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $400.0K | -63.6% |
| Prokidney Corp. (PROK) | 2025-12-31 | $6.58M | +21.0% |
| Pluri Inc. (PLUR) | 2026-06-30 | $511.0K | +61.7% |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | $2.48M | +8.7% |
| Scinai Immunotherapeutics Ltd. (SCNI) | 2025-12-31 | $1.42M | -13.8% |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | $117.1K | +2.8% |
Compare VIVS, ATYR, CRDF, IMA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗